GLP KeepFit knowledge library

Detailed GLP-1 guidance, organized by real user questions.

This is the structured reference layer for GLP KeepFit. It covers starting fit, drug and brand differences, side-effect timing, symptom-by-symptom solutions, stopping and restarting, and the main GLP support products users already compare.

Pages

Clear guides for the questions people ask most often.

Structure

Start, dose changes, side effects, food, recovery, and product comparisons.

Best use

Read by problem first.

Pick the question you are facing now, then open the most relevant guide.

Browse by category

All pages Start Here1 Drugs & Brands1 Side Effects & Timeline2 Symptom Solutions12 Stopping & Restarting3 App & Brand Comparisons1

Molecule-level and brand-level comparisons for semaglutide, tirzepatide, liraglutide, and the labels, titration curves, and GI profiles that matter to users.

Quick reference

Drugs & Brands at a glance

Drug comparison essentials

Question	What users should compare
Molecule	Semaglutide vs tirzepatide vs liraglutide
Label	Weight-management label vs diabetes label
Cadence	Weekly versus daily injections
Support load	How many active titration windows the journey creates

Drugs & Brands11 min readApr 17, 2026

GLP-1 drug and brand comparison: Wegovy, Ozempic, Zepbound, Mounjaro, Saxenda

A practical comparison of the major GLP-1 and GIP/GLP-1 drugs users ask about most: how the molecules differ, what the branded labels mean, which titration windows are longest, and where GI burden tends to show up.

This page includes

Which brands map to which molecules and indications
How semaglutide, tirzepatide, and liraglutide differ in cadence and escalation length
Which drugs show the heaviest GI burden signals in obesity labeling
Why users should compare molecule plus support path, not just brand popularity

Key data point

20 wk

Tirzepatide standard climb to 15 mg in obesity treatment

drug comparisonWegovyZepbound

Read page